Welcome Visitor Saturday, October 5, 2024

Articles related to NASDAQ


Venture Notes - July 11, 2023
Venture Notes - July 11, 2023

Twenty-three items on new funds, startups and early-growth businesses, people in transition, state programs and more.

Read More
LaunchTN IMPACT group grows to 21, with $65.4MM SSBCI decisions due
LaunchTN IMPACT group grows to 21, with $65.4MM SSBCI decisions due

If Tennessee enlists for SSBCI funding, TTDC investment committee could get pretty busy.

Read More
IMAC Regeneration IPO prices with modest target and broader aims
IMAC Regeneration IPO prices with modest target and broader aims

[updated] Completing process, this startup's listing could help with elite athlete partners, banks, investors.

Read More
Drumbeat: Another signal on HealthStream's blockchain interest
Drumbeat: Another signal on HealthStream's blockchain interest

Canaccord analysts weigh-in with their view of relevance of blockchain for listed HSTM and others.

Read More
INVESTTennessee convenes June 21, registration offered VNC readers
INVESTTennessee convenes June 21, registration offered VNC readers
Tractor Supply, AmSurg, Regal Entertainment and 7 other TN companies will present
Read More
Gary Ferguson named chief healthcare strategist for TIBCO Software
Gary Ferguson named chief healthcare strategist for TIBCO Software
Former NotifyMD joins a major player in the
Read More
INVEST TN draws Barron's scribe, CCA, Tractor Supply
INVEST TN draws Barron's scribe, CCA, Tractor Supply
Local publicly held companies get a rare shot at doing their roadshows in Music City, rather than the Big Apple
Read More
Cumberland IPO now active: 10-year journey with Vanderbilt reaches milestone
Cumberland IPO now active: 10-year journey with Vanderbilt reaches milestone
[UPDATED Aug. 11, 6:53 a.m.] Cumberland Pharmaceuticals' IPO filing became effective yesterday and trades today as CPIX, 27 months after the shelf registration and 20 subsequent amendments
Read More
BioMimetic shakes-off FDA bruise,<Br> carves-out Biotechnology niche
BioMimetic shakes-off FDA bruise,
carves-out Biotechnology niche

Now, after selling its first FDA-approved product to a close ally, BioMimetic is flush with cash and experience -- and committed to developing biotechnologies in Middle Tennessee.

Read More

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: